AlphAIalphai — Financial news for AI agents
yahoo.comJUL 136 min read$TOST

Goldman Sachs does an about-face on overlooked software stock

Goldman Sachs upgraded Toast (TOST) to Buy from Neutral on July 9, raising its price target to $36 from $30. TOST had fallen about 19% over six months versus a 7.4% S&P 500 gain. Goldman cites improving fundamentals and expects Toast IQ Grow to lift SaaS revenue per user. Toast reported Q1 annualized recurring revenue up 26% to $2.2B.

Original reporting
yahoo.com
Published Jul 13, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 13, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Goldman Sachs does an about-face on overlooked software stock — source image
Source · yahoo.com
Decision brief

The 30-second read

$TOSTBullishMed
01

Why it matters

Goldman’s upgrade reframes TOST as undervalued with a concrete growth catalyst (Toast IQ Grow) and cites early customer outcomes and adoption scale to justify the higher valuation.

02

Market read

A specific sell-side upgrade with a raised target plus early AI adoption metrics can drive short-term trading interest and re-rating expectations for TOST.

03

What to watch

The article cites analyst targets and adoption counts, but does not provide churn, cohort retention, or whether the 8% sales lift is incremental versus normal seasonality.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session positioning following the July 9 upgrade and the next-day close near $29.32

Background

Toast has lagged broader AI enthusiasm, drifting lower despite improving fundamentals, according to the article’s setup.

Company-level read

Ticker impact

$TOSTBullishMedium confidence
Context

Goldman upgraded Toast to buy from neutral on July 9, lifting its price target to $36 from $30, after the stock closed near $29.32 the next day.

Expected impact

Likely near-term support from upgrade-driven flows, with follow-through dependent on continued traction in Toast IQ Grow and SaaS ARPU.

Evidence & confidence

The article provides a specific, time-stamped rating change and target revision, plus early adoption metrics (8% sales lift, ~40,000 weekly locations) that support the thesis.

Market effects

Sector

Supports the broader narrative that restaurant SaaS and payments platforms can re-rate when AI features show measurable customer revenue impact.

Regional

No specific regional impact described beyond US-listed market performance comparisons.

Global

Limited, as the catalysts and metrics are company-specific to Toast’s US restaurant customer base.

Counterpoint

What could challenge this read

The upgrade may be sentiment-driven, and the early AI results (8% sales lift) may not yet translate into durable ARPU growth or margin expansion.

Key entities

  • company
    Toast

    Restaurant payments and software provider; subject of Goldman’s upgrade and the AI product thesis (Toast IQ Grow).

  • financial_institution
    Goldman Sachs

    Issued the rating change to buy from neutral and raised the price target to $36 from $30.

  • analyst
    Will Nance

    Goldman analyst cited as arguing Toast is undervalued with improving fundamentals and AI-driven monetization.

Read at source← All news

Related articles

AUG 6
$TOSTMed

Boosted Google Maps – Digital Transactions

Google announced Ask Maps in Google Maps, using Gemini AI to let users order food via multi-step requests and route-based restaurant selection. Square (Block) and Toast are early POS partners, syncing menus and enabling checkout through Square or Toast apps. Uber Eats support is coming, and Toast will promote $5 Toast Cash for orders via Ask Maps.

digitaltransactions.net6 min
AUG 6
$TOSTMed

Toast stock rises on AI-powered Google Maps ordering feature

Toast (NYSE:TOST) shares rose 2.75% after the company said it expanded its integration with Google to enable AI-powered ordering via Google Maps. Through Ask Maps, users can view a Toast restaurant menu and place orders directly, with orders routed through Toast’s ordering system. Toast will offer $5 Toast Cash for next orders, with launch expected in late August.

investing.com3 min
AUG 5
$TOSTMedAI 8/10

Toast Adds Record 9,500 Restaurants While Betting Big on AI

Toast reported Q2 record net location adds of 9,500, 1,000 above its prior high, and continued double-digit growth in core business, according to the company. CEO Aman Narang said Toast IQ Grow is its fastest-growing offering. Toast forecast Q3 non-GAAP subscription and fintech gross profit of $615M-$625M and adjusted EBITDA of $210M-$220M.

pymnts.com4 min
AUG 4
$TOSTMed

Toast (NYSE:TOST) Surprises With Q2 CY2026 Sales

Toast (NYSE:TOST) reported Q2 CY2026 revenue of $1.91 billion, up 23.1% year on year and 1.8% above estimates, with GAAP EPS of $0.26, 28.2% above consensus. The article cites ARR of $2.4 billion and notes a negative CAC payback period. It also mentions full-year EBITDA guidance slightly above estimates and next-quarter EBITDA guidance slightly below, with shares down 1.3% to $33.38.

financialcontent.com6 min
JUL 17
$TOSTMed

Toast’s Comeback Story Is Getting Harder for Wall Street to Ignore

Toast, Inc. (NYSE: TOST) is seeing renewed analyst focus on its Toast IQ AI platform. Goldman Sachs upgraded TOST to Buy and set a $36 price target, citing expected gains in average revenue per user and continued account growth. Toast reported about 7,000 net new locations and 26% YoY ARR growth to $2.2B in Q1 2026, while AI-related costs may pressure margins.

yahoo.com6 min
JUL 13
$CECOMed

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

The article lists five “upside” stock calls from Wall Street. JPMorgan initiated CECO Environmental (CECO) with a $130 target, citing AI data center demand and Thermon. It also targets PRM at $50. Goldman upgraded Toast (TOST) to Buy at $36. BofA raised Ligand (LGND) target to $388. Revolution Medicines (RVMD) reported Phase 3 pancreatic cancer results for daraxonrasib, with median OS 13.2 vs 6.7 months.

yahoo.com7 min